A review is carried out to examine the risk of patients suffering from diabetes mellitus in the context of general morbidity and mortality and related to infection by SARS-CoV-2. Likewise, the general recommendations for food and the prevention of comorbidities that most these patients suffer most frequently are also studied. Finally, a review of the pharmacological recommendations on both oral and parenteral treatment in the outpatient, in hospitalization and in critical states infected with SARS-CoV-2 is made.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.24875/ACM.M20000074 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!